Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 2/2020

01-04-2020 | Mefenamic Acid | Research Article

High-risk nonsteroidal anti-inflammatory drugs prescribing in primary care: results from National Medical Care Survey Malaysia

Authors: Wen Yea Hwong, Yvonne Mei Fong Lim, Ee Ming Khoo, Sheamini Sivasampu

Published in: International Journal of Clinical Pharmacy | Issue 2/2020

Login to get access

Abstract

Background Information on the extent of high-risk prescribing for nonsteroidal anti-inflammatory drugs (NSAIDs) across developing countries is scarce. Objectives This study examines the prescribing pattern for NSAIDs in primary care, assesses the extent of high-risk NSAIDs prescribing and identifies associated factors. Setting 129 public and 416 private primary care clinics in Malaysia. Methods Data were derived from the National Medical Care Survey 2014, a cross-sectional survey on primary care morbidity patterns and clinical activities in Malaysia. Types of NSAIDs, indications for NSAIDs use and proportion of high-risk NSAIDs prescribing were assessed. Factors associated with high-risk NSAIDs prescribing were identified with a multivariable logistic regression. Weighted results, adjusted for sampling design and non-response were presented. Main outcome measures Prescribing pattern of NSAIDs, proportion of high-risk NSAIDs prescribing and its associated factors. Results Among the 55,489 patients who received NSAIDs, diclofenac was the most frequently prescribed NSAID (40.5%, 95% CI 40.1–40.9%), followed by mefenamic acid (29.2%, 95% CI 28.8–29.6%). The commonest indications for NSAIDs use were musculoskeletal condition and respiratory tract infection, both at 17.8% (95% CI 17.4–18.1%). A total of 22.9% (95% CI 22.6–23.3%) patients received high-risk NSAID prescriptions. Of these, 47.8% (95% CI 46.9–48.7%) did not receive adequate gastroprotection despite being at risk, 24.8% (95% CI 24.0–25.5%) were prescribed NSAIDs despite having cardiovascular comorbidities and 22.4% (95% CI 21.7–23.2%) were prescribed high-dose NSAIDs. The odds of receiving high-risk NSAID prescriptions increased with the number of drugs prescribed (OR 1.23, 95% CI 1.06–1.43) and the number of diagnoses in one visit (OR 2.21, 95% CI 1.71–2.86). The odds of being prescribed high-risk NSAID prescriptions were lower in patients with secondary (OR 0.52, 95% CI 0.35–0.77) and tertiary education (OR 0.39, 95% CI 0.22–0.68) compared to patients without formal education. Patients’ citizenship, indication for NSAID prescriptions and whether a medical certificate was issued were also significantly associated with the likelihood of receiving high-risk NSAID prescriptions. Conclusions A quarter of NSAIDs prescribed in Malaysian primary care setting is categorised as high-risk prescribing. Targeted strategies are necessary to improve patient safety.
Literature
1.
go back to reference Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63:136–47.CrossRef Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63:136–47.CrossRef
2.
go back to reference Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med. 1998;105:31s–8s.CrossRef Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med. 1998;105:31s–8s.CrossRef
3.
go back to reference Risser A, Donovan D, Heintzman J, Page T. NSAID prescribing precautions. Am Fam Physician. 2009;80:1371–8.PubMed Risser A, Donovan D, Heintzman J, Page T. NSAID prescribing precautions. Am Fam Physician. 2009;80:1371–8.PubMed
4.
go back to reference Schjerning Olsen AM, Fosbol EL, Gislason GH. The impact of NSAID treatment on cardiovascular risk—insight from Danish observational data. Basic Clin Pharmacol Toxicol. 2014;115:179–84.CrossRef Schjerning Olsen AM, Fosbol EL, Gislason GH. The impact of NSAID treatment on cardiovascular risk—insight from Danish observational data. Basic Clin Pharmacol Toxicol. 2014;115:179–84.CrossRef
5.
go back to reference Dreischulte T, Guthrie B. High-risk prescribing and monitoring in primary care: how common is it, and how can it be improved? Ther Adv Drug Saf. 2012;3:175–84.CrossRef Dreischulte T, Guthrie B. High-risk prescribing and monitoring in primary care: how common is it, and how can it be improved? Ther Adv Drug Saf. 2012;3:175–84.CrossRef
6.
go back to reference Al-Shidhani A, Al-Rawahi N, Al-Rawahi A. Non-steroidal anti-inflammatory drugs (NSAIDs) use in primary health care centers in A’Seeb, Muscat: a clinical audit. Oman Med J. 2015;30:366–71.CrossRef Al-Shidhani A, Al-Rawahi N, Al-Rawahi A. Non-steroidal anti-inflammatory drugs (NSAIDs) use in primary health care centers in A’Seeb, Muscat: a clinical audit. Oman Med J. 2015;30:366–71.CrossRef
7.
go back to reference Guthrie B, Donnan PT, Murphy DJ, Makubate B, Dreischulte T. Bad apples or spoiled barrels? Multilevel modelling analysis of variation in high-risk prescribing in Scotland between general practitioners and between the practices they work in. BMJ Open. 2015;5:e008270.CrossRef Guthrie B, Donnan PT, Murphy DJ, Makubate B, Dreischulte T. Bad apples or spoiled barrels? Multilevel modelling analysis of variation in high-risk prescribing in Scotland between general practitioners and between the practices they work in. BMJ Open. 2015;5:e008270.CrossRef
8.
go back to reference Hawkey CJ, Cullen DJ, Seager JM, Holmes S, Doherty M, Wilson JV, et al. Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices. Aliment Pharmacol Ther. 2000;14:177–85.CrossRef Hawkey CJ, Cullen DJ, Seager JM, Holmes S, Doherty M, Wilson JV, et al. Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices. Aliment Pharmacol Ther. 2000;14:177–85.CrossRef
9.
go back to reference Koffeman AR, Valkhoff VE, Celik S, W’t Jong G, Sturkenboom MC, Bindels PJ, et al. High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study. Br J Gen Pract. 2014;64:e191–8.CrossRef Koffeman AR, Valkhoff VE, Celik S, W’t Jong G, Sturkenboom MC, Bindels PJ, et al. High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study. Br J Gen Pract. 2014;64:e191–8.CrossRef
10.
go back to reference Dhabali AA, Awang R, Hamdan Z, Zyoud SH. Associations between prescribing nonsteroidal anti-inflammatory drugs and the potential prescription-related problems in a primary care setting. Int J Clin Pharmacol Ther. 2012;50:851–61.CrossRef Dhabali AA, Awang R, Hamdan Z, Zyoud SH. Associations between prescribing nonsteroidal anti-inflammatory drugs and the potential prescription-related problems in a primary care setting. Int J Clin Pharmacol Ther. 2012;50:851–61.CrossRef
11.
go back to reference Sivasampu S, Wahab Y, Ong S, Ismail S, Goh P, Jeyaindran S. National Medical Care Statistics Primary Care 2014: National Clinical Research Centre Ministry of Health Malaysia 2014. Sivasampu S, Wahab Y, Ong S, Ismail S, Goh P, Jeyaindran S. National Medical Care Statistics Primary Care 2014: National Clinical Research Centre Ministry of Health Malaysia 2014.
14.
go back to reference Lanza FL, Chan FK, Quigley EM. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104:728–38.PubMed Lanza FL, Chan FK, Quigley EM. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104:728–38.PubMed
15.
go back to reference McGinn D. Polypharmacy medicine optimisation review (PMOR): protocol for prescribing NSAIDs initiation, review & discontinuation. August 2014. McGinn D. Polypharmacy medicine optimisation review (PMOR): protocol for prescribing NSAIDs initiation, review & discontinuation. August 2014.
17.
go back to reference Scottish Government Model of Care Polypharmacy Working Group. Polypharmacy guidance. 2nd ed. Edinburgh: Scottish Government; 2015. Scottish Government Model of Care Polypharmacy Working Group. Polypharmacy guidance. 2nd ed. Edinburgh: Scottish Government; 2015.
18.
go back to reference Graham JW. Missing data analysis: making it work in the real world. Annu Rev Psychol. 2009;60:549–76.CrossRef Graham JW. Missing data analysis: making it work in the real world. Annu Rev Psychol. 2009;60:549–76.CrossRef
19.
go back to reference Chua SS, Paraidathathu T. Utilisation of non-steroidal anti-inflammatory drugs (NSAIDs) through community pharmacies in Malaysia. Asia Pac J Public Health. 2005;17:117–23.CrossRef Chua SS, Paraidathathu T. Utilisation of non-steroidal anti-inflammatory drugs (NSAIDs) through community pharmacies in Malaysia. Asia Pac J Public Health. 2005;17:117–23.CrossRef
20.
go back to reference McGettigan P, Henry D. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med. 2013;10:e1001388.CrossRef McGettigan P, Henry D. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med. 2013;10:e1001388.CrossRef
21.
go back to reference Khairudin KA, Jatau AI, Manan MM, Chua ST, Chitneni M, Abdullah AH, et al. Utilization pattern of non-steroidal anti-inflammatory drugs at a primary health care in Malaysia. Indian J Pharm Educ Res. 2017;51:156–61.CrossRef Khairudin KA, Jatau AI, Manan MM, Chua ST, Chitneni M, Abdullah AH, et al. Utilization pattern of non-steroidal anti-inflammatory drugs at a primary health care in Malaysia. Indian J Pharm Educ Res. 2017;51:156–61.CrossRef
22.
go back to reference Kim SY, Chang YJ, Cho HM, Hwang YW, Moon YS. Non-steroidal anti-inflammatory drugs for the common cold. Cochrane Database Syst Rev. 2015;9:CD006362. Kim SY, Chang YJ, Cho HM, Hwang YW, Moon YS. Non-steroidal anti-inflammatory drugs for the common cold. Cochrane Database Syst Rev. 2015;9:CD006362.
23.
go back to reference Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 1991;115:787–96.CrossRef Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 1991;115:787–96.CrossRef
24.
go back to reference Thiefin G, Schwalm MS. Underutilization of gastroprotective drugs in patients receiving non-steroidal anti-inflammatory drugs. Dig Liver Dis. 2011;43:209–14.CrossRef Thiefin G, Schwalm MS. Underutilization of gastroprotective drugs in patients receiving non-steroidal anti-inflammatory drugs. Dig Liver Dis. 2011;43:209–14.CrossRef
25.
go back to reference Valkhoff VE, van Soest EM, Sturkenboom MC, Kuipers EJ. Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs). Aliment Pharmacol Ther. 2010;31:1218–28.CrossRef Valkhoff VE, van Soest EM, Sturkenboom MC, Kuipers EJ. Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs). Aliment Pharmacol Ther. 2010;31:1218–28.CrossRef
26.
go back to reference Vanderstraeten G, Lejeune TM, Piessevaux H, De Bacquer D, Walker C, De Beleyr B. Gastrointestinal risk assessment in patients requiring non-steroidal anti-inflammatory drugs for osteoarthritis: the GIRANO study. J Rehabil Med. 2016;48:705–10.CrossRef Vanderstraeten G, Lejeune TM, Piessevaux H, De Bacquer D, Walker C, De Beleyr B. Gastrointestinal risk assessment in patients requiring non-steroidal anti-inflammatory drugs for osteoarthritis: the GIRANO study. J Rehabil Med. 2016;48:705–10.CrossRef
27.
go back to reference Lee HL, Chua SS, Mahadeva S. Utilization of gastroprotective strategies for nonsteroidal anti-inflammatory drug-induced gastrointestinal events in a major teaching hospital. Ther Clin Risk Manag. 2016;12:1649–57.CrossRef Lee HL, Chua SS, Mahadeva S. Utilization of gastroprotective strategies for nonsteroidal anti-inflammatory drug-induced gastrointestinal events in a major teaching hospital. Ther Clin Risk Manag. 2016;12:1649–57.CrossRef
28.
go back to reference Verbeeck RK, Blackburn JL, Loewen GR. Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs. Clin Pharmacokinet. 1983;8:297–331.CrossRef Verbeeck RK, Blackburn JL, Loewen GR. Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs. Clin Pharmacokinet. 1983;8:297–331.CrossRef
29.
go back to reference Kovac SH, Saag KG, Curtis JR, Allison J. Association of health-related quality of life with dual use of prescription and over-the-counter nonsteroidal antiinflammatory drugs. Arthritis Rheum. 2008;59:227–33.CrossRef Kovac SH, Saag KG, Curtis JR, Allison J. Association of health-related quality of life with dual use of prescription and over-the-counter nonsteroidal antiinflammatory drugs. Arthritis Rheum. 2008;59:227–33.CrossRef
30.
go back to reference McGettigan P, Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med. 2011;8:e1001098.CrossRef McGettigan P, Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med. 2011;8:e1001098.CrossRef
31.
go back to reference Ble A, Masoli JA, Barry HE, Winder RE, Tavakoly B, Henley WE, et al. Any versus long-term prescribing of high risk medications in older people using 2012 Beers Criteria: results from three cross-sectional samples of primary care records for 2003/4, 2007/8 and 2011/12. BMC Geriatr. 2015;15:146.CrossRef Ble A, Masoli JA, Barry HE, Winder RE, Tavakoly B, Henley WE, et al. Any versus long-term prescribing of high risk medications in older people using 2012 Beers Criteria: results from three cross-sectional samples of primary care records for 2003/4, 2007/8 and 2011/12. BMC Geriatr. 2015;15:146.CrossRef
32.
go back to reference Onder G, Landi F, Cesari M, Gambassi G, Carbonin P, Bernabei R. Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly. Eur J Clin Pharmacol. 2003;59:157–62.CrossRef Onder G, Landi F, Cesari M, Gambassi G, Carbonin P, Bernabei R. Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly. Eur J Clin Pharmacol. 2003;59:157–62.CrossRef
33.
go back to reference Xu RH, Wong EL. Involvement in shared decision-making for patients in public specialist outpatient clinics in Hong Kong. Patient Prefer Adherence. 2017;11:505–12.CrossRef Xu RH, Wong EL. Involvement in shared decision-making for patients in public specialist outpatient clinics in Hong Kong. Patient Prefer Adherence. 2017;11:505–12.CrossRef
34.
go back to reference Fraenkel L, Peters E. Patient responsibility for medical decision making and risky treatment options. Arthritis Rheum. 2009;61:1674–6.CrossRef Fraenkel L, Peters E. Patient responsibility for medical decision making and risky treatment options. Arthritis Rheum. 2009;61:1674–6.CrossRef
35.
go back to reference Pearson SA, Moxey A, Robertson J, Hains I, Williamson M, Reeve J, et al. Do computerised clinical decision support systems for prescribing change practice? A systematic review of the literature (1990-2007). BMC Health Serv Res. 2009;9:154.CrossRef Pearson SA, Moxey A, Robertson J, Hains I, Williamson M, Reeve J, et al. Do computerised clinical decision support systems for prescribing change practice? A systematic review of the literature (1990-2007). BMC Health Serv Res. 2009;9:154.CrossRef
36.
go back to reference Avery AJ, Rodgers S, Cantrill JA, Armstrong S, Cresswell K, Eden M, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet. 2012;379:1310–9.CrossRef Avery AJ, Rodgers S, Cantrill JA, Armstrong S, Cresswell K, Eden M, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet. 2012;379:1310–9.CrossRef
37.
go back to reference Kaplan SH, Greenfield S, Ware JE Jr. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care. 1989;27:S110–27.CrossRef Kaplan SH, Greenfield S, Ware JE Jr. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care. 1989;27:S110–27.CrossRef
38.
go back to reference Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med. 1998;104:413–21.CrossRef Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med. 1998;104:413–21.CrossRef
Metadata
Title
High-risk nonsteroidal anti-inflammatory drugs prescribing in primary care: results from National Medical Care Survey Malaysia
Authors
Wen Yea Hwong
Yvonne Mei Fong Lim
Ee Ming Khoo
Sheamini Sivasampu
Publication date
01-04-2020
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 2/2020
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-00966-w

Other articles of this Issue 2/2020

International Journal of Clinical Pharmacy 2/2020 Go to the issue